Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Scientists at the University of Pittsburgh School of Medicine discovered a surprising new way the body can fight insulin resistance and diabetes – by boosting a special type of "good" immune cell in ...

Harding Loevner reviews the Global Developed Markets Equity strategy's 2025 performance amidst narrowing US market ...

This research topic focuses on the intricate interplay between the host immune response and potential therapeutic targets. Viral infections can exacerbate allergic conditions by dysregulating the ...

Surgery remains one of the most effective treatments for localized cancer. The primary aim is complete tumor removal with ...